A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Rcmi-Clinical Research Center
Rio Piedras, PR, Puerto Rico
- Veterans Administration Greater Los Angeles Health Care System
Los Angeles, California, United States
- University of Colorado
Aurora, Colorado, United States
- Western Nephrology and Metabolic Bone Disease, Pc
Westminster, Colorado, United States
- Kidney Care Associates, Llc
Augusta, Georgia, United States
- Circle Medical Management
Chicago, Illinois, United States
- Davita Dialysis Unit 494/nephrology Specialists, Pc
Michigan City, Indiana, United States
- Dept of Internal Medicine, Nephrology & Hypertension
New Orleans, Louisiana, United States
- Washington Nephrology Associates
Bethesda, Maryland, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- Western New England Renal & Transplant Associates, Pc
Springfield, Massachusetts, United States
- Nephrology Hypertension Clinic, Pc
Dearborn, Michigan, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Rochester Hills Davita Dialysis
Pontiac, Michigan, United States
- Asheville Kidney Center
Asheville, North Carolina, United States
- Metrolina Nephrology Associates, Pa
Charlotte, North Carolina, United States
- Duke University Dept of Medicine/nephrology
Durham, North Carolina, United States
- Piedmont Dialysis Center
Winston-Salem, North Carolina, United States
- Clinical Research Limited
Canton, Ohio, United States
- University of Cincinnati
Cincinnati, Ohio, United States
- University of Pennsylvania Health System
Philadelphia, Pennsylvania, United States
- Southeast Renal Research Institute Nephrology Associates
Chattanooga, Tennessee, United States
- Nephrology Associates, Pc
Nashville, Tennessee, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Ut Southwestern Medical Center at Dallas
Dallas, Texas, United States
- Kidney Associates, Pllc
Houston, Texas, United States
- Kidney Specialists of North Houston, Pllc
Houston, Texas, United States
- Med Center Dialysis
Houston, Texas, United States
- University of Vermont/ Fletcher Allen Health Care: Renal Services
Burlington, Vermont, United States
- Nephrology Clinical Research Center
Charlottesville, Virginia, United States
- Clinical Research & Consulting Center, Llc
Fairfax, Virginia, United States
- Nephrology Associates of Northern Virginia, Inc.
Fairfax, Virginia, United States
- Butler Farms Dialysis
Hampton, Virginia, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2012
- Primary completion
- 30 Jun 2014
- Completion
- 31 Aug 2014
- Last update posted
- 13 Jul 2016
- Registered enrollment
- 168
- Registry id
- NCT01554982
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.